BioHealth News
Maryland Stem Cell Research Commission Announces Release of Requests for Applications for its Grant Programs
COLUMBIA, Md. (May 30, 2024) – The Maryland Stem Cell Research Commission (“the Commission”) announces the release of Requests for Applications (RFAs) for the…
Read More
Gaithersburg’s Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch
GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced the clearance of its second Investigational New…
Read More
Linshom Medical Receives $100K MIPS award and Launches Clinical Study with Univ. of Maryland School of Medicine Faculty
BALTIMORE, MD, US, May 29, 2024 /EINPresswire.com/ -- Linshom Medical, a Maryland-based startup developing a wearable respiratory monitoring system, announced today that it has…
Read More
AMPEL BioSolutions Building Evidence for Prognostic Potential of Lupus Molecular Subtyping Test
NEW YORK – AMPEL BioSolutions is recruiting individuals with systemic lupus erythematosus (SLE) into an observational study of its blood-based prognostic gene expression assay LuGene…
Read More
ATCC Announces Award from NIAID to Provide Antiviral Screening Assays Relevant to Human Diseases
MANASSAS, Va.--(BUSINESS WIRE)--ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a task order with a…
Read More
Precision for Medicine Acquires Algorics, Enhancing Clinical Technologies and APAC Presence
The acquisition adds two proprietary clinical technologies to its portfolio and enhances Precision's global capabilities in clinical data management, biostatistics and programming. BETHESDA, Maryland,…
Read More
Celebrating Excellence: Maryland Tech Council 2024 ICON Award Winners
BioHealth Innovation Inc. (BHI) congratulates the outstanding winners of the 2024 ICON Awards announced by the Maryland Tech Council. These awards recognize the incredible…
Read More
Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
ROCKVILLE, Md., May 23, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the…
Read More
Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startups
RICHMOND, Va., May 23, 2024 /PRNewswire/ -- Activation Capital announces the launch of Frontier BioHealth, an educational and support program designed to provide highly specialized training,…
Read More
ARPA-H’s NITRO selects teams to lead breakthroughs in reversing OA
Program performer teams to develop innovative ways for joints to heal themselves The Advanced Research Projects Agency for Health (ARPA-H), an agency within the…
Read More
Rockville’s Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer
ROCKVILLE, Md., May 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and…
Read More
Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies
Nona Biosciences, a global biotechnology company providing a total solution from “Idea to IND” (I to ITM), ranging from target validation and antibody discovery…
Read More
Frederick’s Theradaptive Secures $1M in Funding from Maryland Stem Cell Research Fund for Human Clinical Trials
FREDERICK, Md., May 22, 2024 /PRNewswire/ -- Theradaptive, Inc., a regenerative medicine company developing targeted therapeutics, announced today it has been awarded funding from the Maryland…
Read More
PQE Group US Earns Great Place to Work Certification™
Rockville, MD, May 22, 2024. PQE Group is proud to announce that, for the third consecutive year, its US subsidiary has been Certified™ by…
Read More
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
Legend Biotech obtains license to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its non-viral engineered pipeline portfolio across a variety of…
Read More